Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum
- PMID: 29506490
- PMCID: PMC5839060
- DOI: 10.1186/s12881-018-0548-2
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum
Abstract
Background: Rubinstein-Taybi syndrome (RSTS) is a rare autosomal dominant neurodevelopmental disorder characterized by broad thumbs and halluces. RSTS is caused by mutations in CREBBP and in EP300 genes in 50-60% and 8%, respectively. Up to now, 76 RSTS-EP300 patients have been described. We present the clinical and molecular characterization of a cohort of RSTS patients carrying EP300 mutations.
Methods: Patients were selected from a cohort of 72 individuals suspected of RSTS after being negative in CREBBP study. MLPA and panel-based NGS EP300 were performed.
Results: Eight patients were found to carry EP300 mutations. Phenotypic characteristics included: intellectual disability (generally mild), postnatal growth retardation, infant feeding problems, psychomotor and language delay and typical facial dysmorphisms (microcephaly, downslanting palpebral fissures, columella below the alae nasi, and prominent nose). Broad thumbs and/or halluces were common, but angulated thumbs were only found in two patients. We identified across the gene novel mutations, including large deletion, frameshift mutations, nonsense, missense and splicing alterations, confirming de novo origin in all but one (the mother, possibly underdiagnosed, has short and broad thumbs and had learning difficulties).
Conclusions: The clinical evaluation of our patients corroborates that clinical features in EP300 are less marked than in CREBBP patients although it is difficult to establish a genotype-phenotype correlation although. It is remarkable that these findings are observed in a RSTS-diagnosed cohort; some patients harbouring EP300 mutations could present a different phenotype. Broadening the knowledge about EP300-RSTS phenotype may contribute to improve the management of patients and the counselling to the families.
Keywords: Broad thumbs; EP300; EP300-RSTS-phenotype; EP300-Rubinstein-Taybi; EP300-mutations; Intellectual disability; RSTS; RSTS-2.
Conflict of interest statement
Ethics approval and consent to participate
This work has been approved by the Committee for Ethics in Clinical Research in La Rioja (CEICLAR). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study or from their parents in the case of minors.
Consent for publication
Consent Form for Publication of personal information in a scientific journal, including clinical data and image and photographs was obtained from all individual participants included in the study or from their parents in the case of minors.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures


Similar articles
-
Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations.Am J Med Genet A. 2016 Dec;170(12):3069-3082. doi: 10.1002/ajmg.a.37940. Epub 2016 Sep 20. Am J Med Genet A. 2016. PMID: 27648933
-
First case report of inherited Rubinstein-Taybi syndrome associated with a novel EP300 variant.BMC Med Genet. 2016 Dec 13;17(1):97. doi: 10.1186/s12881-016-0361-8. BMC Med Genet. 2016. PMID: 27964710 Free PMC article.
-
Genetic and clinical heterogeneity in Korean patients with Rubinstein-Taybi syndrome.Mol Genet Genomic Med. 2021 Oct;9(10):e1791. doi: 10.1002/mgg3.1791. Epub 2021 Aug 24. Mol Genet Genomic Med. 2021. PMID: 34427995 Free PMC article.
-
Rubinstein-Taybi syndrome: clinical features, genetic basis, diagnosis, and management.Ital J Pediatr. 2015 Jan 20;41:4. doi: 10.1186/s13052-015-0110-1. Ital J Pediatr. 2015. PMID: 25599811 Free PMC article. Review.
-
Rubinstein-Taybi Syndrome and Epigenetic Alterations.Adv Exp Med Biol. 2017;978:39-62. doi: 10.1007/978-3-319-53889-1_3. Adv Exp Med Biol. 2017. PMID: 28523540 Free PMC article. Review.
Cited by
-
Enhancers: bridging the gap between gene control and human disease.Hum Mol Genet. 2018 Aug 1;27(R2):R219-R227. doi: 10.1093/hmg/ddy167. Hum Mol Genet. 2018. PMID: 29726898 Free PMC article. Review.
-
Rubinstein-Taybi Syndrome: A Model of Epigenetic Disorder.Genes (Basel). 2021 Jun 24;12(7):968. doi: 10.3390/genes12070968. Genes (Basel). 2021. PMID: 34202860 Free PMC article. Review.
-
Chiari 1 malformation and exome sequencing in 51 trios: the emerging role of rare missense variants in chromatin-remodeling genes.Hum Genet. 2021 Apr;140(4):625-647. doi: 10.1007/s00439-020-02231-6. Epub 2020 Dec 18. Hum Genet. 2021. PMID: 33337535 Free PMC article.
-
A novel CREBBP mutation and its phenotype in a case of Rubinstein-Taybi syndrome.BMC Med Genomics. 2022 Aug 19;15(1):182. doi: 10.1186/s12920-022-01335-4. BMC Med Genomics. 2022. PMID: 35986282 Free PMC article.
-
New insights into genetic variant spectrum and genotype-phenotype correlations of Rubinstein-Taybi syndrome in 39 CREBBP-positive patients.Mol Genet Genomic Med. 2019 Nov;7(11):e972. doi: 10.1002/mgg3.972. Epub 2019 Sep 30. Mol Genet Genomic Med. 2019. PMID: 31566936 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous